Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain EXEL message board posts where the ticker symbol EXEL has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

Related news from
Thu, 28 Mar 2024
12:13:14 +0000
Insiders Are Dumping These 10 Healthcare Stocks
In this article, we will take a detailed look at Insiders Are Dumping These 10 Healthcare Stocks. For a quick overview of such stocks, read our article Insiders Are Dumping These 5 Healthcare Stocks. Healthcare-focused investors were nervous when 2024 started, since election years usually do not bode well for the healthcare industry amid policy-related uncertainties. But healthcare stocks […]
Sat, 23 Mar 2024
09:06:00 +0000
4 Magnificent Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market
Phenomenal deals can still be found, even with the Nasdaq Composite climbing to a new all-time high.
Thu, 21 Mar 2024
12:21:38 +0000
Exelixis, Inc.'s (NASDAQ:EXEL) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Exelixis' (NASDAQ:EXEL) stock is up by a considerable 16% over the past month. However, we decided to pay attention to...
Sun, 17 Mar 2024
12:50:16 +0000
30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world. If you do not want to learn about the global biotech market, head straight to the 5 Biggest Biotechnology Companies in the World. In the ever-evolving landscape of biotechnology, several companies like Novo Nordisk, Regeneron, and United […]
Wed, 13 Mar 2024
15:30:14 +0000
Why Is Immunovant, Inc. (IMVT) Down 14.7% Since Last Earnings Report?
Immunovant, Inc. (IMVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Mon, 11 Mar 2024
14:36:00 +0000
The Zacks Analyst Blog Highlights Legend Biotech, Exact Sciences, Exelixis, Ascendis Pharma and MorphoSys
Legend Biotech, Exact Sciences, Exelixis, Ascendis Pharma and MorphoSys are part of the Zacks top Analyst Blog.
Fri, 08 Mar 2024
14:38:44 +0000
10 Biotech Stocks with Huge Potential
In this article, we will take a look at the 10 biotech stocks with huge potential. To skip our analysis of the recent trends, and market activity, you can go directly to see the 5 Biotech Stocks with Huge Potential. Recent developments, technological as well as optimism related to interest rate reductions, have led to […]
Fri, 08 Mar 2024
13:15:00 +0000
2 Biotech Stocks to Buy Hand Over Fist in March
These stocks are worth buying in most months of the year.
Thu, 07 Mar 2024
16:31:04 +0000
Why Is Exelixis (EXEL) Up 10.9% Since Last Earnings Report?
Exelixis (EXEL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Thu, 07 Mar 2024
15:08:53 +0000
10 Mid-Cap Stocks with Insider Purchases
In this article, we will take a detailed look at the 10 Mid-Cap Stocks with Insider Purchases. For a quick overview of such stocks, read our article 5 Mid-Cap Stocks with Insider Purchases. Investors are yet again in a wait-and-see mode ahead of key jobs and inflation numbers, but the overall sentiment in the market is positive, helped […]
Wed, 06 Mar 2024
21:45:00 +0000
3 Cutting-Edge Biotech Stocks Sitting on the Brink of Success
Biotech stocks have always been high-risk and high-reward, with the futures and fortunes of companies often decided with a single successful drug trial or Federal Drug Administration (FDA) approval. The right company can yield extravagant returns for the lucky or prudent investor. However, choosing the wrong ones can lead to losses just as significant as the potential wins. Therefore, due diligence is important. A company announcing that it is developing a cure for cancer, MS, Huntington’s, or H
Wed, 06 Mar 2024
16:40:15 +0000
EXEL vs. REGN: Which Stock Is the Better Value Option?
EXEL vs. REGN: Which Stock Is the Better Value Option?
Sat, 02 Mar 2024
10:06:00 +0000
4 Thrilling Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market
The growth-driven Nasdaq Composite has entered a new bull market, but plain-as-day deals can still be found.
Fri, 01 Mar 2024
14:15:09 +0000
ANI Pharmaceuticals, Inc. (ANIP) Hit a 52 Week High, Can the Run Continue?
ANI (ANIP) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Thu, 29 Feb 2024
19:57:04 +0000
Is Now The Time To Put Exelixis (NASDAQ:EXEL) On Your Watchlist?
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
Tue, 27 Feb 2024
21:05:00 +0000
Exelixis to Webcast Fireside Chats as Part of Investor Conferences in March
ALAMEDA, Calif., February 27, 2024--Exelixis, Inc. (Nasdaq: EXEL) today announced that members of the company’s management team will participate in fireside chats at the following investor conferences in March:
Tue, 27 Feb 2024
13:00:03 +0000
Exelixis' Growth Trajectory Depends on Leading Innovations in Cancer Treatments
A closer look at one of the leaders in the renal cell carcinoma market
Mon, 19 Feb 2024
13:00:00 +0000
2 Stocks Under $30 to Buy and Hold
You don't need to be a millionaire to get started. Investing on a budget can work, too.
Wed, 14 Feb 2024
11:00:00 +0000
Zacks Industry Outlook Highlights Sarepta, Exelixis, Immunocore, Editas and Puma Biotechnology
Sarepta, Exelixis, Immunocore, Editas and Puma Biotechnology have been highlighted in this Industry Outlook article.
Wed, 14 Feb 2024
06:47:12 +0000
Jim Simons Increases Stake in Exelixis Inc
Renaissance Technologies, led by Jim Simons (Trades, Portfolio), has recently bolstered its investment in Exelixis Inc (NASDAQ:EXEL), a notable player in the biopharmaceutical industry. The transaction, which took place on December 19, 2023, saw the firm adding 398,800 shares to its holdings, reflecting a 2.62% change in the position size.



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "I joined almost three years ago and have never been sorry. The search features here are terrific." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2024, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards